176 related articles for article (PubMed ID: 7890773)
1. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
[TBL] [Abstract][Full Text] [Related]
3. Activation of TIMP-2/progelatinase A complex by stromelysin.
Miyazaki K; Umenishi F; Funahashi K; Koshikawa N; Yasumitsu H; Umeda M
Biochem Biophys Res Commun; 1992 Jun; 185(3):852-9. PubMed ID: 1320876
[TBL] [Abstract][Full Text] [Related]
4. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
Itoh Y; Binner S; Nagase H
Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix.
Rice A; Banda MJ
Biochemistry; 1995 Jul; 34(28):9249-56. PubMed ID: 7619826
[TBL] [Abstract][Full Text] [Related]
6. APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
Biochemistry; 1996 Aug; 35(34):11221-7. PubMed ID: 8780527
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
8. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
[TBL] [Abstract][Full Text] [Related]
9. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
Ogata Y; Itoh Y; Nagase H
J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
[TBL] [Abstract][Full Text] [Related]
10. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2.
Howard EW; Bullen EC; Banda MJ
J Biol Chem; 1991 Jul; 266(20):13070-5. PubMed ID: 1649175
[TBL] [Abstract][Full Text] [Related]
11. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.
Goldberg GI; Strongin A; Collier IE; Genrich LT; Marmer BL
J Biol Chem; 1992 Mar; 267(7):4583-91. PubMed ID: 1311314
[TBL] [Abstract][Full Text] [Related]
12. An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A.
Crabbe T; Kelly SM; Price NC
FEBS Lett; 1996 Feb; 380(1-2):53-7. PubMed ID: 8603746
[TBL] [Abstract][Full Text] [Related]
13. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B.
O'Connell JP; Willenbrock F; Docherty AJ; Eaton D; Murphy G
J Biol Chem; 1994 May; 269(21):14967-73. PubMed ID: 8195131
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
Benbow U; Butticè G; Nagase H; Kurkinen M
J Biol Chem; 1996 May; 271(18):10715-22. PubMed ID: 8631880
[TBL] [Abstract][Full Text] [Related]
16. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.
Howard EW; Bullen EC; Banda MJ
J Biol Chem; 1991 Jul; 266(20):13064-9. PubMed ID: 2071592
[TBL] [Abstract][Full Text] [Related]
18. Degradation of interleukin 1beta by matrix metalloproteinases.
Ito A; Mukaiyama A; Itoh Y; Nagase H; Thogersen IB; Enghild JJ; Sasaguri Y; Mori Y
J Biol Chem; 1996 Jun; 271(25):14657-60. PubMed ID: 8663297
[TBL] [Abstract][Full Text] [Related]
19. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma.
Moutsiakis D; Mancuso P; Krutzsch H; Stetler-Stevenson W; Zucker S
Connect Tissue Res; 1992; 28(3):213-30. PubMed ID: 1468208
[TBL] [Abstract][Full Text] [Related]
20. Native TIMP-free 70 kDa progelatinase (MMP-2) secreted at elevated levels by RSV transformed fibroblasts.
Stefansson S; Aimes RT; Seward NB; Alexander DS; Quigley JP
J Cell Physiol; 1994 Dec; 161(3):419-28. PubMed ID: 7962125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
